A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/04/2002	EP1152763B1 Use of desoxypeganine for the treatment of drug dependence
12/04/2002	EP1143805B1 Method for reducing incidence of ascites in poultry by aid of natamycin
12/04/2002	EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002	EP1100769B1 Aminomethylcarboxylic acid derivatives
12/04/2002	EP1097139B1 Quinoline derivatives
12/04/2002	EP1077967B1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/04/2002	EP1073417B1 Pharmaceutical aerosol formulation
12/04/2002	EP1058683B1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/04/2002	EP1054671B1 New use of ropivacaine for pain management
12/04/2002	EP1051420B1 New cytotoxic tris(oxazole)-containing macrolides
12/04/2002	EP1022277B1 New taxane derivatives
12/04/2002	EP1014808B1 Fatty acids as a diet supplement
12/04/2002	EP1005342B1 Pharmaceutical compositions of tizoxanide and nitazoxanide
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	EP0984980B1 20-aralkyl-5alpha-pregnane derivatives
12/04/2002	EP0971961B1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/04/2002	EP0971882B1 Nitro-benzamide useful as anti-arrhythmic agent
12/04/2002	EP0939638B1 Injectable formulations of avermectins and milbemycins
12/04/2002	EP0925060B1 Fast decomposing pellets
12/04/2002	EP0917534B1 6,7-oxygenated steroids and uses related thereto
12/04/2002	EP0912561B1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
12/04/2002	EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
12/04/2002	EP0863890B1 5-amidomethyl alpha, betha-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents
12/04/2002	EP0853478B1 New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
12/04/2002	EP0846465B1 Nicorandil against anxiety neurosis
12/04/2002	EP0833640B1 Pharmaceutical composition containing lamotrigine
12/04/2002	EP0821582B1 Controlled release tablet
12/04/2002	EP0820306B1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
12/04/2002	EP0815124B1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/04/2002	EP0802915B1 Camptothecin derivatives and its manufacturing method
12/04/2002	EP0800390B1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
12/04/2002	EP0781135B1 Codeine containing formulations
12/04/2002	EP0765662B1 Use of 5,6-o-benzylidene-l-ascorbic acid or salts thereof for the manufacture of a medicament for the treatment of hiv
12/04/2002	EP0752863B1 Use of biopolymers for digestive tract injuries treatment
12/04/2002	EP0742218B1 Pyrrolopyridazine derivative
12/04/2002	EP0711152B1 Powder-layered oral dosage forms
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0690856B1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
12/04/2002	EP0650356B1 Rapamycin derivatives
12/04/2002	CN1383428A Medicinal compsns. having antiplasmid effect and its prepn. method
12/04/2002	CN1383427A Process for preparing N6-substituted deaza-adenosine derivatives
12/04/2002	CN1383426A Obesity inhibitory materials
12/04/2002	CN1383386A Drug delivery device for insertion in vagina, rectum of nasal cavity
12/04/2002	CN1383383A Oxygen-contg. ophthalmic compsn.
12/04/2002	CN1383382A Use of methoxymorpholino dexorubicin for treatment of liver tumor
12/04/2002	CN1383381A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives
12/04/2002	CN1383379A Method of treatment of seborrheic dermatitis
12/04/2002	CN1383375A Treatment of human herpesviruses using hyperthermia
12/04/2002	CN1382682A 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage
12/04/2002	CN1382679A Process for extracting free anthraquinone from rhuhbarb and its medical application
12/04/2002	CN1382493A Diarylprophin photosensitizer and its preparing process and usage
12/04/2002	CN1382490A Treatment application of selectivity PDE10 suppressant
12/04/2002	CN1382479A External-applied Chinese medicine for treating hypertension and its preparing process
12/04/2002	CN1382449A Compound haparin aqueogel and its preparing process
12/04/2002	CN1382447A Quick-acting ointment for treating dermatitis and eczema
12/04/2002	CN1382446A Application of Funaosu in preventing and treating cadiovascular and cerebrovascular diseases
12/04/2002	CN1382445A Veterinary licking antihelmintic
12/04/2002	CN1382444A Viginal medicine for treating gynopathy
12/04/2002	CN1382443A Application of Na-ion channel blocker in preparing medicine for local nerve anesthesia or analgesia
12/04/2002	CN1382442A Method for preventing dyskinesia
12/04/2002	CN1382441A Application of gammalon transporter inhibitor in preparing analgesic
12/04/2002	CN1382440A Method and medicine case for treating depression or preventing degeneration of cognitive function
12/04/2002	CN1382439A Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis
12/04/2002	CN1382438A Repercussive and antipruritic cream and its preparing process
12/04/2002	CN1382437A Application of epigallic catechin 3-gallate in treating HPV infection
12/04/2002	CN1382436A Slowly releasing analgesic and its preparing process
12/04/2002	CN1382435A Application of sodium ferulate in preparing medicine to prevent and cure heptofibrosis
12/04/2002	CN1382433A Use of sunshading agent compsn. contg. malonic dialkyl ester in cosmetics and medicinal preparation
12/04/2002	CN1382375A Pediculus and nit killing compsns. and method for killing head pediculus and its nit
12/04/2002	CN1095472C Folica acid-polysaccharide composite and its prepn. and medical compsn. with composite as active component
12/04/2002	CN1095471C Method for processing lentinan protein
12/04/2002	CN1095466C Soya total flavone, its prepn. method and medical use thereof
12/04/2002	CN1095375C Medicated cosmetics capable of treating primary and secondary varicose vein simultaneously and its prepn. method
12/04/2002	CN1095371C Capsule for treating bone diseases
12/04/2002	CN1095366C Application of N-aceto-aminoglucose in medicinal preparation for curing intestinal diseases
12/04/2002	CN1095365C Method for raising sow conception, farrowing and survical rate by using vitamin E
12/04/2002	CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy
12/03/2002	US6489514 (-)-Secoisolariciresinol as an antioxidant obtained from a new natural source namely stereospermum personatum
12/03/2002	US6489495 Cationic amphiphiles for liposomal gene transfer
12/03/2002	US6489488 Serotonin (5-ht) subtype 6 receptor (5-ht6); 3-(2-aminoethyl)indole derivatives; drug screening
12/03/2002	US6489486 2-hydroxyphenyl benzotriazoles as UV-A/B filters
12/03/2002	US6489481 Compounds used for treatment and/or prevention of neuronal apoptosis and/or excitotoxicity related neurological disorders
12/03/2002	US6489478 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
12/03/2002	US6489477 Nmda nr2b antagonists. accordingly, another aspect of the invention is the treatment of pain, migraine, depression, anxiety, schizophrenia, parkinson's disease, or stroke--maladies that are amenable to amelioration through
12/03/2002	US6489476 Fructose-1,6-bisphosphatase enzyme inhibitors are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
12/03/2002	US6489475 Method of producing heterocyclic derivatives
12/03/2002	US6489464 Branched oligonucleotides as pathogen-inhibitory agents
12/03/2002	US6489448 Antibody to a protein with thiol specific antioxidant (tsa) activity; vaccines
12/03/2002	US6489445 Polypeptides which specifically bind to at least one human bone morphogenic protein (bmp) selected from bmp-5 and bmp-6
12/03/2002	US6489395 Comprising oligoesters; use such as in hand lotions; can be used without nonionic surfactants as emulsifier
12/03/2002	US6489369 Insoluble or sparingly water soluble drugs such as etoposide, paclitaxel, propofol or cyclosporins, biodegradable/ -compatible sterol solubilizers, carriers and diluents having storage stability
12/03/2002	US6489367 Semifluorinated alkanes and the use thereof
12/03/2002	US6489366 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002	US6489363 For therapy of sleepiness, tiredness, parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, attention deficit hyperactivity disorder, cognitive dysfunction or fatigue, stimulation of appetite
12/03/2002	US6489362 Suitable for use with all young meat-type chickens where the desired effect is a decrease in the incidence of ascites; in feed or water supply
12/03/2002	US6489361 Calcium formate for binding phosphorus in the gastrointestinal tract and, thus, reducing phosphorus absorption from the intestine
12/03/2002	US6489358 Pharmaceutical compositions containing mupirocin
12/03/2002	US6489357 Tobacco cembranoids block the expression of the behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptors

1 ... 5633 5634 5635 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 5653 ... 7860